<- Go Home
Worldwide Biotech & Pharmaceutical Company
Worldwide Biotech & Pharmaceutical Company, a biotech company, develops and markets viruses/viral vectors, external diagnostic reagents, prophylactic vaccines, and oral solid dosage forms for humans in China and Southeast Asia. It offers products for hepatitis C virus, diagnostic medicines, and over-the-counter drugs. The company works with pharmaceutical research institutes, and establishes connections with central and local governments. Worldwide Biotech & Pharmaceutical Company was founded in 2001 and is headquartered in Xi'an, China.
Market Cap
$377.4K
Volume
11.6K
Cash and Equivalents
$98.1K
EBITDA
-$647.1K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$93.4K
Profit Margin
1060.59%
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.12
Price / Earnings
-0.33
Price / Tangible Book Value
-0.10
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.1M
Return on Equity
48.16%
Return on Assets
-12.46
Cash and Short Term Investments
$98.1K
Debt
$3.5M
Equity
-$3.7M
Revenue
$8.8K
Unlevered FCF
$2.7M
Sector
Biotechnology
Category
N/A